Last Updated: June 24, 2026

Suppliers and packagers for neffy


✉ Email this page to a colleague

« Back to Dashboard


neffy

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Ars Pharms Operation NEFFY epinephrine SPRAY;NASAL 214697 NDA Medical Purchasing Solutions, LLC 71872-7330-1 1 BLISTER PACK in 1 BAG (71872-7330-1) / 1 VIAL, SINGLE-DOSE in 1 BLISTER PACK / 100 uL in 1 VIAL, SINGLE-DOSE 2024-08-09
Ars Pharms Operation NEFFY epinephrine SPRAY;NASAL 214697 NDA ARS Pharmaceuticals Operations, Inc. 82580-010-02 2 BLISTER PACK in 1 CARTON (82580-010-02) / 1 VIAL, SINGLE-DOSE in 1 BLISTER PACK / 100 uL in 1 VIAL, SINGLE-DOSE 2025-03-05
Ars Pharms Operation NEFFY epinephrine SPRAY;NASAL 214697 NDA ARS Pharmaceuticals Operations, Inc. 82580-020-02 2 BLISTER PACK in 1 CARTON (82580-020-02) / 1 VIAL, SINGLE-DOSE in 1 BLISTER PACK / 100 uL in 1 VIAL, SINGLE-DOSE 2024-08-09
Ars Pharms Operation NEFFY epinephrine SPRAY;NASAL 214697 NDA Sportpharm LLC 85766-129-02 2 BLISTER PACK in 1 CARTON (85766-129-02) / 1 VIAL, SINGLE-DOSE in 1 BLISTER PACK / 100 uL in 1 VIAL, SINGLE-DOSE 2025-03-05
Ars Pharms Operation NEFFY epinephrine SPRAY;NASAL 214697 NDA Sportpharm LLC 85766-130-02 2 BLISTER PACK in 1 CARTON (85766-130-02) / 1 VIAL, SINGLE-DOSE in 1 BLISTER PACK / 100 uL in 1 VIAL, SINGLE-DOSE 2024-08-09
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for neffy

Last updated: May 27, 2026

Neffy (epinephrine) nasal spray suppliers: What companies manufacture and supply the drug product, device, and components

Neffy is an FDA-approved, epinephrine nasal spray product supplied in the US via a branded manufacturing and packaging chain built around the intranasal delivery system and sterile drug product manufacturing. Identifying the exact set of “suppliers” depends on what you mean by supplier (drug product manufacturer, finished-goods packager, device/component supplier, or distribution/wholesaler).

No complete, reliable supplier mapping for “Neffy” (manufacturer names tied to specific product strength(s), labeler codes, and Orange Book/NDC-to-manufacturer links) is provided in the information available in this conversation. Per constraints, no partial supplier list is included.

What companies supply Neffy nasal spray drug product manufacturing?

A complete supplier answer requires linking Neffy’s NDC(s) to FDA/Orange Book labeler, listed manufacturer(s), and any applicable FDA facility listings for drug substance and drug product manufacture. That mapping is not present in the provided inputs.

Which manufacturing sites make Neffy (drug product) under FDA inspections?

A manufacturing site list requires the specific Neffy NDA number, NDCs, and the corresponding FDA facility/establishment identifiers. Those identifiers are not provided.

Which firms supply the Neffy intranasal device and packaging components?

Neffy’s “suppliers” can include the intranasal spray device components (sprayer, metering parts, closure/labeling system) and finished packaging. A component supplier map requires documented supplier disclosures (e.g., FDA CMC summaries, DMFs, inspector observations, NDA supplements, or supplier-part numbering in procurement records). None are provided here.

What device platform does Neffy use and who provides it?

Device supplier identification requires the device description from the NDA and any referenced device master file or contractual manufacturing disclosures, which are not included.

How does the Orange Book list Neffy’s labeler and manufacturers?

Orange Book listing requires the drug’s NDA identifier and the Orange Book entry for Neffy. Without the NDA number and Orange Book dataset lines, a correct listing is not possible.

What is Neffy’s Orange Book status and listing details?

Orange Book status (listed patents, expiration dates, and whether Neffy has listed exclusivity/protection) requires the Orange Book record. No Orange Book record is provided.

What suppliers support Neffy distribution in the US (wholesalers vs. direct)?

Distribution suppliers and wholesale partners vary by market contracts and time period. A reliable list requires NDC distribution data or labeler/distributor mapping, which is not included.

Which labeler (NDC) maps to which distributor for Neffy?

NDC-to-distributor mapping requires NDCs and labeler code records, not present in the input.

Which companies have manufacturing or supply-chain disputes involving Neffy?

Patent litigation and supply disputes are trackable only with litigation docket data, consent decrees, or FDA shortage/CMC enforcement records tied to specific suppliers. None are provided.

What recalls or shortages indicate specific supplier constraints for Neffy?

Recalls and shortages require FDA recall database links or FDA drug shortage notifications tied to Neffy and dates. No such records are present here.

How do biosimilar or generic competition affect Neffy’s supplier set?

Competition affects capacity planning and sometimes prompts secondary sourcing. A supplier impact analysis requires known generic/alternative entrants, their manufacturing partners, and the extent of substitution. No entry list is provided.

Key takeaways

  • A complete, accurate supplier list for Neffy cannot be produced from the provided information.
  • A correct supplier map requires NDC-to-labeler-to-manufacturer linkages and FDA/Orange Book record details, none of which are included here.

FAQs

  1. What is the NDA number for Neffy (epinephrine) nasal spray so suppliers can be identified from FDA records?
  2. How do I map Neffy NDC codes to drug product manufacturers and packagers?
  3. Which FDA databases show Neffy manufacturing sites by establishment ID?
  4. Where do I find intranasal device component supplier information for Neffy?
  5. How can I determine Neffy’s labeler vs. distributor on the NDC?

References

No sources were provided or cited in the information available for this response.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.